increased susceptibility to experimental autoimmune myasthenia gravis_Cd55<tm1Song>/Cd55<tm1Song>

http://metadb.riken.jp/0004823B6129S6Cd55tm1SongCd55tm1SongCd55tm1SongCd55tm1Song

increased susceptibility to experimental autoimmune myasthenia gravis_Cd55<tm1Song>/Cd55<tm1Song>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• CD55 molecule, decay accelerating factor for complement
  http://metadb.riken.jp/db/mgi_rdf/MGI:104850

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cd55<tm1Song>/Cd55<tm1Song>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cd55<tm1Song>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6.129S6-Cd55<tm1Song>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased susceptibility to experimental autoimmune myasthenia gravis
  http://purl.obolibrary.org/obo/MP_0004823

文献

http://purl.org/net/cito/citesAsAuthority

• B P. Morgan, et.al., The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice., Clinical and experimental immunology, 2006, 146
  http://rdf.ncbi.nlm.nih.gov/pubmed/17034582